Intravenous Iron Dextran (High Molecular Weight)
Treatment for Iron Deficiency Anemia
Typical Dosage: Variable, up to 1000 mg total in single or multiple infusions
Effectiveness
87%
Safety Score
60%
Clinical Trials
50
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
Variable, up to 1000 mg total in single or multiple infusions
Time to Effect
2-4 weeks
Treatment Duration
Single dose or several days
Evidence Quality
HIGHNumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
50(Treat 50 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$350
Monitoring:$2,600
Side Effect Mgmt:$200
Total Annual:$3,150
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$70,000/QALY
QALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$3,706
Cost per Remission
$4,065
Comparison vs Oral Ferrous Sulfate
Cost Difference
+$2,680/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Prescription Access Economics
Risk Assessment
Requires Monitoring
YesNeeds lab work/checkups
Intravenous Iron Dextran (High Molecular Weight) Outcomes
for Iron Deficiency Anemia
Efficacy Outcomes
Overall Effectiveness
+87%
Response Rate
+85%
Remission Rate
+77.5%
Common Side Effects
Fever, chills, arthralgia (iron-dextran reaction)
+7%
Hypotension
+2%
Nausea
+1%
Headache
+1%
Anaphylactic reactions
+0.6%
Skin staining (extravasation)
+0.5%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov